Boncresa Injection, Solution
Product Images NDC 70121-2702

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Boncresa (NDC 70121-2702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

First Figure (Boncresa Denosumab Mobz Injection 1)

An instructional diagram showing a two-part comparison of a syringe before and after use. The 'Before use' side labels the plunger, clear finger grip, transparent safety guard, window, and gray needle cap. The 'After use' side labels the used plunger, used needle safety spring, and gray needle cap removed, illustrating the syringe components in both states.*

FDA Label Image

Step 1 (Boncresa Denosumab Mobz Injection 2)

An instructional illustration showing two hands handling a syringe, with one hand holding the syringe barrel and the other hand pulling upward on a cap or cover from the needle, indicated by a black upward arrow. The syringe is depicted in transparent outline to show internal parts.*

FDA Label Image

Step 2a (Boncresa Denosumab Mobz Injection 3)

An anatomical illustration showing recommended subcutaneous injection sites for Boncresa (denosumab-mobz) injection. The labeled sites include the upper arm, abdomen, and upper thigh, each marked with shaded areas indicating injection locations on a human figure.*

FDA Label Image

Step 2b (Boncresa Denosumab Mobz Injection 4)

An instructional illustration showing a person administering a subcutaneous injection with a syringe into the forearm of another person. One hand holds the syringe vertically against the skin while the other supports the arm. A downward arrow indicates the direction of injection.*

FDA Label Image

Step 3a (Boncresa Denosumab Mobz Injection 5)

An instructional illustration showing hands administering a subcutaneous injection using a syringe or autoinjector. One hand holds the device perpendicular to the skin, while the other hand stabilizes the area. An arrow above indicates the direction of injection, moving upward from the skin.*

FDA Label Image

Step 3b (Boncresa Denosumab Mobz Injection 6)

An instructional illustration showing the administration of an injection into a patient's arm using a prefilled syringe. One hand holds the syringe in a vertical position against the skin, while the other steadies the arm. The image demonstrates preparation for a subcutaneous injection.*

FDA Label Image

Figure 1 (Boncresa Denosumab Mobz Injection 7)

A line graph showing patient hip fracture incidence (%) over a 36-month study period comparing Denosumab versus placebo. The y-axis represents patient hip fracture incidence percentage from 0 to 10%, and the x-axis represents study months from 0 to 36. Denosumab is represented by a solid line, and placebo by a dashed line, with patient numbers around 3900 in each group.*

FDA Label Image

Carton (Boncresa Denosumab Mobz Injection 8)

Boncresa 60 mg/mL (denosumab-mobz) Injection, solution for subcutaneous use, displayed on a single-dose prefilled syringe carton. The label highlights storage instructions and manufacturer information by Amneal Pharmaceuticals LLC. The packaging includes a barcode, product NDC 70121-2702, and usage caution to dispense the enclosed Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.